Table 2 Percent change from mean baseline normalized to a scale of Ā± 4
Assay | Epitope | 1 | 2 | 3 | 4 |
|---|---|---|---|---|---|
MHC tetramer | EBV BMLF1259ā267 | ā„85.89 | ā„171.78 | ā„257.67 | ā„343.56 |
| Ā | CMVpp65495ā503 | ā„69.89 | ā„138.58 | ā„207.87 | ā„277.16 |
| Ā | MART126ā35 | ā„107.29 | ā„214.58 | ā„321.87 | ā„429.16 |
| Ā | Tyrosinase368ā376 | ā„107.29 | ā„214.58 | ā„321.87 | ā„429.16 |
| Ā | gp100209ā217 | ā„107.29 | ā„214.58 | ā„321.87 | ā„429.16 |
IFN-Ī³ ELISPOT | EBV BMLF1259ā267 | ā„246.85 | ā„493.7 | ā„740.55 | ā„987.4 |
| Ā | CMVpp65495ā503 | ā„192.4 | ā„384.8 | ā„577.2 | ā„769.6 |
| Ā | MART126ā35 | ā„264.1 | ā„528.2 | ā„792.3 | ā„1,056.4 |
| Ā | Tyrosinase368ā376 | ā„264.1 | ā„528.2 | ā„792.3 | ā„1,056.4 |
| Ā | gp100209ā217 | ā„264.1 | ā„528.2 | ā„792.3 | ā„1,056.4 |
HLA-DR | Ā | 0 ā 50 | 51 ā 100 | 101 ā 150 | 150 ā 200+ |
CD45RO | Ā | 0 ā 50 | 51 ā 100 | 101 ā 150 | 150 ā 200+ |
QPCR | Ā | 0 ā 50 | 51 ā 100 | 101 ā 150 | 150 ā 200+ |